ChinaHealthcare and life sciences2025 – ongoingHuadong Medicine
AI-assisted drug-discovery platform for internal research
Huadong Medicine reported that its AI drug-discovery platform supported 22 research projects
Problem
Drug-discovery teams needed to screen candidate molecules and assess competing research. These tasks required analysis of scientific and development data.
Approach
Huadong built an AI-assisted drug-discovery platform with competitive-research analysis and molecular prediction tools. Its protein-drug module supported interaction prediction and constrained structure generation. The company applied the platform to internal research projects across different drug types.
Results
Takeaway
The disclosed figures measured research activity and platform use. Huadong did not quantify the reduction in development time or improvement in candidate quality.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- IT and R&D
- Innovation type
- Process innovation
- AI technology
- Generative AIPredictive analytics and ML
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
Huadong described AI tools integrated into its drug-discovery work. It reported support for 22 research projects and the generation of more than 1 million candidate molecules during 2025.
Full details are in the original sources.